RGTI Rigetti Computing Stock Outlook 2026: Can Superconducting Qubits Finally Close the Gap?

Here is a proposition worth testing: the most interesting quantum computing investment may not be the one with the most revenue today, but the one building the hardware everyone else will eventually need.

Rigetti Computing occupies an unusual position. It is not the largest player by revenue — IonQ has it beat by a wide margin. It is not the biggest name — IBM and Google have that covered. But Rigetti is the only publicly traded company running its own superconducting quantum fab, selling cloud QPU access, and doing it without a major cloud hyperscaler as a corporate parent. That full-stack independence is either its defining advantage or a liability, depending on how the next 18 months play out.

Let’s look at what the numbers actually say.

---

Business Model: How Rigetti Makes (and Loses) Money

Rigetti’s revenue comes from three channels.

Cloud QPU Access Customers pay for compute time on Rigetti’s quantum systems through the Rigetti Quantum Cloud Services (QCS) platform, and also via Amazon Braket and Microsoft Azure Quantum. This is the recurring-revenue dream, but at current quantum workloads, usage is nowhere near software-as-a-service volumes.

On-Premises System Sales Rigetti sells its Novera QPU (24 qubits) and larger systems directly to research institutions and governments. Revenue is lumpy — it spikes when a system ships. The $8.4M C-DAC (India) order for a 108-qubit system, announced in January 2026 and expected to ship in H2 2026, is a good example. Similarly, two purchase orders totaling approximately $5.7M were announced in late 2025.

Government Grants and Research Contracts Federal agencies including DARPA and the Department of Energy have historically supported Rigetti. This funding is harder to predict than commercial revenue and can shift with policy priorities.

---

Verified Financials: Q1 2026 and Full-Year 2025

Q1 2026, reported May 2026:

Metric	Q1 2026
Revenue	$4.4M
YoY Revenue Growth	~+193%
Operating Loss	-$26.0M
GAAP Net Income	+$33.1M*
Non-GAAP Net Loss	-$14.7M
Cash & Investments	$569.0M
Total Debt	$0

*The GAAP net income figure includes non-cash derivative fair-value gains. It does not reflect the underlying operating reality, which remains a significant loss.

Full-year 2025 results (reported March 2026):

• Revenue: $7.1M
• GAAP Net Loss: $216.2M
• Non-GAAP Net Loss: $50.5M

Revenue beat the analyst consensus of $4.13M, but the stock still fell roughly 7% on earnings day. When a company trades at a valuation this rich, beating estimates by a small margin can still disappoint.

---

Technology Roadmap: Chiplets as the Scaling Strategy

The central bet at Rigetti is that chiplet-based modular architecture is the right way to scale superconducting qubits. Instead of building one massive chip (high yield risk), Rigetti connects many smaller, individually tested chiplets.

Key milestones:

Ankaa-3 — 84 qubits, launched December 2024. Achieved 99.5% median two-qubit gate fidelity.

Cepheus-1-108Q — 108 qubits, generally available in early 2026. Twelve 9-qubit chiplets interconnected. Using a proprietary adiabatic CZ gate scheme, Rigetti reported 99.8% two-qubit gate fidelity at 40-nanosecond gate speeds on its 9-qubit test module.

Lyra — 336 qubits, targeted for late 2026. Goal: 99.7% two-qubit gate fidelity. This is the system Rigetti believes can demonstrate narrow quantum advantage on real-world optimization problems for the first time.

UK 1,000+ Qubit System — Announced March 2026, with up to $100M planned investment and a three-to-four year deployment timeline in the UK.

The qubit count matters less than fidelity. A 500-qubit machine with 98% gate fidelity is nearly useless at depth. A 100-qubit machine at 99.8% is genuinely interesting. Rigetti’s fidelity progress is the metric worth tracking most closely alongside qubit count.

---

Competitive Landscape

Rigetti competes in what is essentially a multi-modal arms race. Different qubit technologies each have proponents, and no approach has decisively won.

IBM (superconducting) — Heron R2, 156 qubits, publicly available in the US and EU. IBM’s advantage is its 10+ years of enterprise sales relationships and one of the deepest quantum software stacks in the industry.

Google (superconducting) — Willow chip, impressive error-correction benchmarks. Google’s quantum work is largely research-driven, with commercial availability unclear.

IonQ (trapped-ion) — Stronger revenue ($64.7M in Q1 2026 vs. Rigetti’s $4.4M). High fidelity per qubit, harder to scale by sheer qubit count. See the IonQ 2026 outlook analysis for a direct comparison.

Microsoft (topological) — Majorana 1 chip announced early 2025. Targets topological qubits that could theoretically scale dramatically faster. Science is contested; timeline to practical systems is long.

D-Wave — Quantum annealing specialist, different market segment than gate-based players.

Rigetti’s specific niche: the only independent, full-stack superconducting QPU company accessible via all three major cloud platforms simultaneously. That multi-cloud neutrality is a selling point for customers who do not want platform lock-in.

---

Bull, Base, and Bear Scenarios

Bull case — Lyra ships on schedule in late 2026 and demonstrates measurable narrow quantum advantage on a supply-chain or materials-science optimization problem. The C-DAC India system ships on time, generating $8.4M in H2 revenue. UK partnership advances with additional government commitments. Full-year 2026 revenue approaches $25–30M, and analyst estimates (Zacks consensus implies +248% growth for 2026) are met or exceeded. The valuation multiple sustains at elevated levels.

Base case — Cepheus cloud revenue grows steadily, C-DAC ships as scheduled. Lyra slips slightly to Q1 2027 but technical benchmarks remain on track. Revenue comes in around $15–20M for the year. Operating losses continue. Stock trades in a range, reacting sharply to each roadmap announcement.

Bear case — IBM or Google makes a notable quantum advantage announcement that draws cloud customer attention away from smaller players. Lyra faces a technical setback. Government grant revenue disappoints. The market re-rates the sector downward, compressing multiples across all pure-play quantum names. Rigetti’s $569M cash cushion prevents existential risk, but the stock could retrace significantly.

---

Valuation: The Math on $8.5 Billion

On 2025 annual revenue of $7.1M, RGTI’s current ~$8.5B market cap implies a price-to-sales ratio of roughly 1,200×. There is no conventional framework that justifies that number based on current fundamentals.

What the market is pricing is option value: the possibility that quantum computing becomes a multi-billion-dollar industry and Rigetti captures a meaningful share. This is not unusual for frontier technology stocks, but it does mean the stock is essentially a binary on technology execution.

For US investors, the long-term capital gains rate (0%, 15%, or 20% depending on income) applies to positions held more than one year. Given RGTI’s volatility — the stock has traded from $10.30 to $58.15 in its 52-week range — tax-loss harvesting opportunities may arise regardless of the long-term thesis. Track your cost basis carefully if building a position over time.

---

Who Is Actually Buying Rigetti’s QPU?

Understanding the demand side helps calibrate how seriously to take the revenue ramp.

Academic and research institutions form the most consistent part of the customer base. They use Rigetti QCS to run quantum algorithm experiments, test error-correction schemes, and prototype hybrid quantum-classical workflows. These customers generate modest individual billings but are sticky, and their published research acts as organic technical validation for the platform.

Government labs and agencies represent the large-ticket opportunity. India’s C-DAC ($8.4M) and the UK National Quantum Computing Centre (which already runs a 36-qubit Rigetti system as part of an error-correction consortium) illustrate this well. Procurement cycles are long, but a single deal can equal several quarters of cloud revenue. The CHIPS Act letter of intent signed with the U.S. Department of Commerce in May 2026 adds another potential domestic funding channel.

Financial and enterprise explorers are running experimental workloads — portfolio optimization, risk modeling, combinatorial search. No commercial quantum advantage has been demonstrated in this sector yet, but the experiments are happening. Rigetti’s presence on both AWS and Azure means enterprise IT teams can try QPU access without a separate procurement process.

The honest assessment: no customer is yet running a business-critical workload on Rigetti that they couldn’t run classically. This is not unique to Rigetti — it applies to the whole industry. But it means the revenue model today is essentially “research tool access,” not “enterprise SaaS.” The switch to the latter depends on Lyra delivering something classically competitive.

---

What “Narrow Quantum Advantage” Actually Means

This term gets tossed around in every quantum computing press release, so it’s worth being precise.

“Quantum advantage” in the broadest sense means a quantum computer solves something faster than a classical machine. Google’s Sycamore achieved this in 2019 on a random circuit sampling problem — a test designed to be hard for classical computers, but one with no practical application.

“Narrow quantum advantage” — the specific claim Rigetti makes for Lyra — means demonstrating a speed or quality improvement on a problem that has actual commercial value. Examples could include specific molecular simulation for drug discovery, constrained optimization for supply chain routing, or financial portfolio optimization under combinatorial constraints.

This distinction matters enormously for the investment thesis. Proving narrow quantum advantage would mean enterprises can calculate a real ROI for using Rigetti’s hardware over classical alternatives. It would be the first time the sales conversation could shift from “interesting experiment” to “this replaces or augments our existing compute spend.”

That is why Lyra is the binary event that will define RGTI’s trajectory into 2027. Not the qubit count — the benchmark results on real problems.

---

US Tax Considerations for RGTI

For US investors, RGTI falls into the standard equity tax treatment:

• Short-term capital gains (held under 12 months): taxed as ordinary income, up to 37% for top brackets.
• Long-term capital gains (held 12+ months): 0%, 15%, or 20% depending on taxable income.

Given RGTI’s extreme volatility — the stock has ranged from $10.30 to $58.15 over the past 52 weeks — the timing of gains and losses can be consequential. If the stock drops significantly while you have gains elsewhere in the portfolio, RGTI could be a tax-loss harvesting candidate to offset those gains.

RGTI pays no dividend, so there are no dividend withholding considerations.

For retirement accounts (IRA, 401k): RGTI is eligible for tax-advantaged accounts. Holding a speculative position inside a Roth IRA, for instance, means any eventual gains would be entirely tax-free — a legitimate structural consideration if you believe the long-term thesis has real upside.

---

My Take: Watch Closely, Hold Position Small

RGTI is not a stock I would buy aggressively at current prices. The valuation leaves almost no margin of error on execution. One Lyra delay or one disappointing technical benchmark could trigger a 30–40% drawdown without any change to the underlying long-term thesis.

That said, I would not dismiss it either. The full-stack superconducting model is a defensible position. The chiplet architecture is intellectually coherent. And $569M in cash with zero debt gives the company real runway to reach the moments that matter.

My practical suggestion: treat RGTI as a 1–2% satellite position within a broader tech or growth allocation. Size it for what you can hold through a 50% drawdown without flinching, because that scenario is entirely plausible. Watch Lyra’s progress as the primary binary event. If Lyra delivers genuine quantum advantage data, the thesis accelerates significantly. If it doesn’t, reassess.

Compare the risk profile here to other early-stage deep-tech plays like QuantumScape, which faces similar “promising but unproven at scale” dynamics in solid-state batteries.

A simple monitoring checklist: (1) Lyra launch timeline and technical benchmark release; (2) C-DAC India delivery completion and any follow-on government contracts; (3) quarterly cloud QPU revenue trajectory — is growth accelerating or decelerating?; (4) any IBM or Google quantum advantage announcement that could shift enterprise sentiment. When these signals move, revisit position sizing accordingly.

The asymmetry here is real: if Lyra works as advertised, RGTI’s current price could look cheap in retrospect. If it doesn’t, the stock will reprice sharply. That binary profile demands position sizing discipline, not a binary opinion on the outcome. Uncertainty is the point — and the reason the upside exists at all.

One final thought: in a sector where IBM, Google, and Microsoft are all competing, the independent pure-play option has historically attracted a premium. Investors who want pure quantum exposure without buying into a broader enterprise software or cloud conglomerate have very few choices. That structural scarcity is part of what sustains RGTI’s elevated multiple. Whether it’s justified depends entirely on Lyra.

Set your entry and exit triggers before you buy. Know what benchmark result from Lyra would confirm your thesis, and what result would cause you to exit. Having those criteria defined in advance is the difference between an investor and a speculator in a sector like this.

---

This article is for informational purposes only and does not constitute investment advice. Key figures verified from: Rigetti Computing Q1 2026 earnings press release (May 2026, via SEC 8-K filings and financial media); Rigetti full-year 2025 results (March 2026, GlobeNewswire); C-DAC India order announcement (January 2026, GlobeNewswire); UK $100M investment announcement (March 2026, GlobeNewswire); Ankaa-3 launch (December 2024, GlobeNewswire); stock price and market cap data from public.com and Macrotrends (June 2026). All investment decisions should be made in consultation with a qualified financial advisor.